Isthmus Partners LLC Lowers Position in Plexus Corp. $PLXS

Isthmus Partners LLC cut its stake in shares of Plexus Corp. (NASDAQ:PLXS) by 51.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,085 shares of the technology company’s stock after selling 13,987 shares during the period. Isthmus Partners LLC’s holdings in Plexus were worth $2,650,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Hodges Capital Management Inc. lifted its position in shares of Plexus by 47.7% during the fourth quarter. Hodges Capital Management Inc. now owns 17,950 shares of the technology company’s stock valued at $2,639,000 after purchasing an additional 5,795 shares in the last quarter. Louisiana State Employees Retirement System bought a new stake in Plexus in the 1st quarter worth about $2,410,000. JPMorgan Chase & Co. grew its position in Plexus by 28.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 240,460 shares of the technology company’s stock worth $34,792,000 after purchasing an additional 52,967 shares in the last quarter. Jefferies Financial Group Inc. purchased a new stake in Plexus in the 4th quarter valued at about $2,182,000. Finally, GSA Capital Partners LLP increased its stake in Plexus by 159.6% in the 4th quarter. GSA Capital Partners LLP now owns 14,638 shares of the technology company’s stock valued at $2,152,000 after buying an additional 8,999 shares during the last quarter. 94.45% of the stock is owned by hedge funds and other institutional investors.

Plexus Trading Up 3.9%

Shares of PLXS stock opened at $265.89 on Thursday. The company has a quick ratio of 0.74, a current ratio of 1.54 and a debt-to-equity ratio of 0.06. The firm has a market cap of $7.12 billion, a P/E ratio of 38.87 and a beta of 0.88. The company has a 50 day moving average of $274.88 and a 200-day moving average of $222.16. Plexus Corp. has a 12-month low of $115.35 and a 12-month high of $307.06.

Plexus (NASDAQ:PLXS) last posted its quarterly earnings data on Wednesday, April 29th. The technology company reported $2.05 EPS for the quarter, beating the consensus estimate of $1.87 by $0.18. Plexus had a return on equity of 12.84% and a net margin of 4.35%.The business had revenue of $1.16 billion for the quarter, compared to the consensus estimate of $1.13 billion. During the same quarter in the prior year, the business earned $1.66 earnings per share. Plexus’s revenue for the quarter was up 18.7% on a year-over-year basis. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. Sell-side analysts anticipate that Plexus Corp. will post 5.98 earnings per share for the current year.

Insider Activity

In other Plexus news, insider Victor (Pang Hau) Tan sold 3,000 shares of the stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $271.23, for a total transaction of $813,690.00. Following the completion of the transaction, the insider owned 10,457 shares in the company, valued at $2,836,252.11. This trade represents a 22.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Angelo Michael Ninivaggi, Jr. sold 3,270 shares of Plexus stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $264.75, for a total transaction of $865,732.50. Following the completion of the transaction, the executive vice president owned 16,266 shares of the company’s stock, valued at $4,306,423.50. The trade was a 16.74% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 21,981 shares of company stock valued at $5,855,318 in the last 90 days. Insiders own 1.78% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on PLXS shares. Zacks Research downgraded Plexus from a “hold” rating to a “strong sell” rating in a research note on Wednesday, May 20th. Needham & Company LLC increased their price target on Plexus from $285.00 to $310.00 and gave the company a “buy” rating in a research report on Monday, June 1st. Benchmark reaffirmed a “buy” rating and set a $220.00 price target on shares of Plexus in a research report on Monday, March 16th. Weiss Ratings upgraded Plexus from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday. Finally, Raymond James Financial reissued an “outperform” rating and issued a $275.00 price objective on shares of Plexus in a research report on Thursday, April 30th. Five equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $246.67.

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.